SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-22-074052
Filing Date
2022-11-21
Accepted
2022-11-21 09:49:17
Documents
100
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0622a1_immucellcorp.htm   iXBRL 10-Q/A 1210434
2 AMENDMENT TO RIGHTS AGREEMENT DATED AS OF AUGUST 10, 2022 f10q0622a1ex4-1_immucell.htm EX-4.1 12657
3 CERTIFICATION f10q0622a1ex31_immucell.htm EX-31 10260
4 CERTIFICATION f10q0622a1ex32_immucell.htm EX-32 5096
  Complete submission text file 0001213900-22-074052.txt   7594403

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE iccc-20220630.xsd EX-101.SCH 99788
6 XBRL CALCULATION FILE iccc-20220630_cal.xml EX-101.CAL 38004
7 XBRL DEFINITION FILE iccc-20220630_def.xml EX-101.DEF 348739
8 XBRL LABEL FILE iccc-20220630_lab.xml EX-101.LAB 691831
9 XBRL PRESENTATION FILE iccc-20220630_pre.xml EX-101.PRE 369917
94 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622a1_immucellcorp_htm.xml XML 1165817
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-12934 | Film No.: 221403798
SIC: 2835 In Vitro & In Vivo Diagnostic Substances